HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Meletios A Dimopoulos Selected Research

Bone Diseases (Bone Disease)

10/2015European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications.
1/2014Conservative treatment of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients.
12/2012Prevention and treatment of myeloma bone disease.
2/2012Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents.
5/2011Advances in imaging and the management of myeloma bone disease.
5/2011Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
10/2010Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
3/2010High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents.
8/2009Pathogenesis and management of myeloma bone disease.
3/2009Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Meletios A Dimopoulos Research Topics

Disease

84Multiple Myeloma
10/2015 - 10/2003
35Neoplasms (Cancer)
01/2016 - 01/2005
23Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2015 - 05/2002
13Amyloidosis
01/2016 - 06/2003
12Bone Diseases (Bone Disease)
10/2015 - 10/2006
12Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 12/2005
10Carcinoma (Carcinomatosis)
01/2015 - 06/2002
8Breast Neoplasms (Breast Cancer)
07/2015 - 04/2006
8Disease Progression
09/2014 - 07/2005
8Peripheral Nervous System Diseases (PNS Diseases)
11/2013 - 01/2004
8Prostatic Neoplasms (Prostate Cancer)
05/2011 - 01/2004
6Neoplasm Metastasis (Metastasis)
01/2016 - 09/2005
5Neutropenia
07/2015 - 06/2004
5Lymphoma (Lymphomas)
09/2014 - 04/2003
5Osteonecrosis (Kienbock's Disease)
01/2014 - 12/2005
5Pain (Aches)
01/2014 - 02/2008
5Paraproteinemias (Monoclonal Gammopathy)
11/2012 - 04/2003
5Monoclonal Gammopathy of Undetermined Significance
09/2012 - 04/2003
5Renal Cell Carcinoma (Grawitz Tumor)
02/2012 - 10/2004
4Renal Insufficiency (Renal Failure)
11/2014 - 08/2009
4Bone Resorption
01/2014 - 03/2010
4Hematologic Neoplasms (Hematological Malignancy)
10/2013 - 12/2005
4Fever (Fevers)
11/2010 - 05/2002
3Anemia
10/2015 - 12/2009
3Infection
01/2015 - 12/2008
3Venous Thromboembolism
09/2013 - 12/2008
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2011 - 04/2003
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 12/2005
2Chromosome Aberrations (Chromosome Abnormalities)
09/2015 - 07/2012
2Thrombocytopenia (Thrombopenia)
01/2015 - 04/2007
2Weight Loss (Weight Reduction)
04/2011 - 02/2008
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2011 - 12/2004
2Spinal Cord Compression
02/2011 - 04/2009

Drug/Important Bio-Agent (IBA)

39bortezomib (Velcade)FDA Link
10/2015 - 12/2005
31Dexamethasone (Maxidex)FDA LinkGeneric
10/2015 - 01/2002
30lenalidomide (CC 5013)FDA Link
10/2015 - 03/2007
18Melphalan (Alkeran)FDA LinkGeneric
04/2015 - 10/2003
17Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 06/2002
16Thalidomide (Thalomid)FDA Link
08/2013 - 10/2003
15PlatinumIBA
01/2015 - 12/2004
14Prednisone (Sone)FDA LinkGeneric
04/2015 - 08/2008
13Cisplatin (Platino)FDA LinkGeneric
01/2013 - 06/2002
11Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015 - 12/2005
11DiphosphonatesIBA
01/2014 - 12/2005
10rituximab (Mabthera)FDA Link
11/2015 - 05/2002
10Immunoglobulin M (IgM)IBA
11/2012 - 04/2003
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 06/2003
7zoledronic acid (zoledronate)FDA Link
10/2015 - 12/2005
7Biological Markers (Surrogate Marker)IBA
11/2014 - 11/2007
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 01/2005
7Carboplatin (JM8)FDA LinkGeneric
01/2011 - 01/2006
6pamidronate (APD)FDA LinkGeneric
10/2015 - 12/2005
6pomalidomideIBA
10/2015 - 01/2013
6L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2015 - 03/2009
5docetaxel (Taxotere)FDA Link
10/2014 - 02/2008
5Alkaline PhosphataseIBA
01/2014 - 04/2011
5CytokinesIBA
01/2013 - 06/2007
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2012 - 01/2006
4Formaldehyde (Formol)FDA Link
10/2014 - 01/2012
4Angiopoietin-1IBA
11/2012 - 06/2007
4Angiopoietin-2IBA
11/2012 - 06/2007
4Methotrexate (Mexate)FDA LinkGeneric
04/2012 - 01/2006
4gemcitabineFDA Link
01/2010 - 01/2006
3Carbon MonoxideIBA
01/2015 - 04/2007
3CreatinineIBA
10/2013 - 03/2009
3ParaffinIBA
01/2013 - 01/2012
3angiogeninIBA
11/2012 - 06/2007
3Staphylococcal Protein A (A, Protein)IBA
07/2012 - 10/2006
3Fluorouracil (Carac)FDA LinkGeneric
04/2012 - 02/2002
3sunitinib (Sutent)FDA Link
02/2012 - 01/2010
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2012 - 12/2004
3HormonesIBA
07/2011 - 01/2004
3Etoposide (VP 16)FDA LinkGeneric
03/2011 - 12/2004
2Amyloid (Amyloid Fibrils)IBA
01/2016 - 02/2010
2Tissue Inhibitor of Metalloproteinase-1IBA
01/2016 - 03/2010
2Hemoglobins (Hemoglobin)IBA
10/2015 - 04/2011
2carfilzomibIBA
01/2015 - 01/2015
2LBH589IBA
01/2015 - 07/2013
2Messenger RNA (mRNA)IBA
10/2014 - 01/2013
2collagen type I trimeric cross-linked peptideIBA
01/2014 - 09/2012
2OsteocalcinIBA
01/2014 - 11/2012
2OsteoprotegerinIBA
01/2014 - 11/2012
2Anti-Bacterial Agents (Antibiotics)IBA
01/2014 - 11/2010
2Cystatin CIBA
10/2013 - 03/2009
2Histone Deacetylase InhibitorsIBA
07/2013 - 01/2011
2Histone Deacetylases (Histone Deacetylase)IBA
07/2013 - 09/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2013 - 09/2010
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
12/2012 - 02/2010
2Clodronic Acid (Clodronate)IBA
12/2012 - 02/2011
2Epirubicin (Ellence)FDA LinkGeneric
04/2012 - 01/2012
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2012 - 06/2007
2Leucovorin (Folinic Acid)FDA Link
01/2011 - 02/2002

Therapy/Procedure

32Drug Therapy (Chemotherapy)
07/2015 - 01/2004
14Stem Cell Transplantation
09/2014 - 01/2003
7Adjuvant Chemotherapy
07/2015 - 04/2006
6Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 12/2005
4Aftercare (After-Treatment)
03/2015 - 10/2003
4Radiotherapy
01/2012 - 01/2003
2Transplantation (Transplant Recipients)
02/2013 - 05/2012
2Therapeutics
01/2013 - 04/2011